FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Venook

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Anatomy

Hepatic Artery

Co-author Network

Publications

TOP 3
Katherine Van Loon; Alan P Venook; Devin Wigler; Donna Niedzwiecki; Leonard Saltz; Charles Blanke; Charles Fuchs; Richard M Goldberg; Jeffrey A Meyerhardt
Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405.
Alan P Venook; Robert S Warren; Xing Ye; Kim Clark-Langone; Wendy Frankel; Paula N Friedman; Richard M Goldberg; Mark Lee; Margarita Lopatin; Najjia N Mahmoud; Carl Millward; Donna Niedzwiecki; Richard L Schilsky; Steven Shak; Monica M Bertagnolli
Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.
Celina S Ang; Marinela Capanu; Michael A Choti; Joanne F Chou; David Peter Cosgrove; Ronald P DeMatteo; Linda Ferrell; Yuman Fong; Ann Griffin; R Katie Kelley; David Klimstra; Jennifer Ma; Joseph McGuire; Eileen M O'Reilly; Timothy M Pawlik; Francesco Stipa; Michael Torbenson; Gandhi P Vallarapu; Alan P Venook; Ghassan K Abou-Alfa
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Venook (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katherine Van Loon; Alan P Venook; Devin Wigler; Donna Niedzwiecki; Leonard Saltz; Charles Blanke; Charles Fuchs; Richard M Goldberg; Jeffrey A Meyerhardt
Comparison of Dietary and Lifestyle Habits Among Stage III and Metastatic Colorectal Cancer Patients: Findings from CALGB 89803 and CALGB 80405.
Clinical colorectal cancer 2013;12(2):95-102.
2013: Alan P Venook; Robert S Warren; Xing Ye; Kim Clark-Langone; Wendy Frankel; Paula N Friedman; Richard M Goldberg; Mark Lee; Margarita Lopatin; Najjia N Mahmoud; Carl Millward; Donna Niedzwiecki; Richard L Schilsky; Steven Shak; Monica M Bertagnolli
Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(14):1775-81.
2013: Celina S Ang; Marinela Capanu; Michael A Choti; Joanne F Chou; David Peter Cosgrove; Ronald P DeMatteo; Linda Ferrell; Yuman Fong; Ann Griffin; R Katie Kelley; David Klimstra; Jennifer Ma; Joseph McGuire; Eileen M O'Reilly; Timothy M Pawlik; Francesco Stipa; Michael Torbenson; Gandhi P Vallarapu; Alan P Venook; Ghassan K Abou-Alfa
Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.
Gastrointestinal cancer research : GCR 2013;6(1):3-9.
2012: Al B Benson; Emily Chan; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Paul F Engstrom; Peter C Enzinger; Marwan G Fakih; Deborah A Freedman-Cass; Charles S Fuchs; Tanios Bekaii-Saab; Jean L Grem; Steven Hunt; Lucille A Leong; Edward Lin; Michael G Martin; Kilian Salerno May; Mary F Mulcahy; Kate Murphy; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; William Small; Constantinos T Sofocleous; Alan P Venook; Christopher G Willett; Kristina M Gregory
Rectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(12):1528-64.
2012: Jeffrey A Meyerhardt; Rex B Mowat; Donna Niedzwiecki; Leonard B Saltz; Kaori Sato; Alan P Venook; Renaud Whittom; Devin S Wigler; Cynthia Ye; Al Benson; Alexander Hantel; Robert J Mayer; Charles S Fuchs
Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of the National Cancer Institute 2012;104(22):1702-11.
2012: Katherine Van Loon; Alan P Venook
Counterpoint: Adjuvant therapy in stage II colon cancer: pain not justified by the gain.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(11):1379-86.
2012: Geoffrey R Oxnard; Alan P Venook; Laurence H Baker; F Stephen Hodi; Mark G Kris; Michael J Morris; Lawrence H Schwartz
When progressive disease does not mean treatment failure: reconsidering the criteria for progression.
Journal of the National Cancer Institute 2012;104(20):1534-41.
2012: Andrew H Ko; Anna Ong; Alan P Venook; Emily K Bergsland; Fergus V Coakley; Elizabeth Dito; Anne M Espinoza; Cherry S Hanover; Kimberly A Jones; Robin K Kelley; Margaret A Tempero
Optimizing the administration of fixed-dose rate gemcitabine plus capecitabine using an alternating-week schedule: a dose finding and early efficacy study in advanced pancreatic and biliary carcinomas.
American journal of clinical oncology 2012;35(5):411-7.
2012: Justin R Parekh; Alan P Venook; Sam C Wang; Robert S Warren; Emily K Bergsland; Grace E Kim; Eric K Nakakura
Lymph node sampling rates and predictors of nodal metastasis in pancreatic neuroendocrine tumor resections: the UCSF experience with 149 patients.
Pancreas 2012;41(6):840-4.
2012: Robin Kelley; Ryutaro Hirose; Alan P Venook
Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012;18(5):509-13.
2012: Al B Benson; Emily Chan; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Paul F Engstrom; Peter C Enzinger; Marwan G Fakih; James W Fleshman; Deborah A Freedman-Cass; Charles S Fuchs; Jean L Grem; Lucille A Leong; Edward Lin; Kilian Salerno May; Mary F Mulcahy; Kate Murphy; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; William Small; Constantinos T Sofocleous; Alan P Venook; Christopher Willett; J Pablo Arnoletti; Tanios Bekaii-Saab
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(4):449-54.
2012: Katherine Van Loon; Alan P Venook
Metastatic colorectal cancer: a curable disease.
Oncology (Williston Park, N.Y.) 2012;26(3):275-6, 282.
2012: Robin Kelley; Alan P Venook; Chloe Atreya; Phillip G Febbo
Predictive biomarkers in advance of a companion drug: ahead of their time?
Journal of the National Comprehensive Cancer Network : JNCCN 2012;10(3):303-9.
2012: Bertrand Janne d'Othée; Matthew S Johnson; Steven J Cohen; Jean-Francois H Geschwind; Nadar N Hanna; Andrew S Kennedy; Robert J Lewandowski; Ravi Murthy; Constantinos T Sofocleous; Michael C Soulen; Jean-Nicolas Vauthey; Alan P Venook; Stephen T Kee
Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel.
Journal of vascular and interventional radiology : JVIR 2012;23(2):153-63.
2011: Robin Kelley; Grace Wang; Alan P Venook
Biomarker use in colorectal cancer therapy.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(11):1293-302.
2011: Al B Benson; Emily Chan; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Paul F Engstrom; Peter C Enzinger; James W Fleshman; Charles S Fuchs; Jean L Grem; James A Knol; Lucille A Leong; Edward Lin; Kilian Salerno May; Mary F Mulcahy; Kate Murphy; Eric Rohren; David P Ryan; Leonard Saltz; Sunil Sharma; David Shibata; John M Skibber; William Small; Constantinos T Sofocleous; Alan P Venook; Christopher Willett; J Pablo Arnoletti; Tanios Bekaii-Saab
Colon cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(11):1238-90.
2011: Kimmie Ng; Donna Niedzwiecki; Shuji Ogino; Leonard B Saltz; Paul L Schaefer; Alan P Venook; Renaud Whittom; Al B Benson; Monica M Bertagnolli; Andrew T Chan; Jennifer A Chan; Richard M Goldberg; Alexander Hantel; Donna Hollis; Robert J Mayer; Jeffrey A Meyerhardt; Charles S Fuchs
Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.
Journal of the National Cancer Institute 2011;103(20):1540-51.
2011: Anne M Espinoza; Alan P Venook
Lactic acidosis and colon cancer: oncologic emergency?
Clinical colorectal cancer 2011;10(3):194-7.
2011: Katherine Van Loon; Alan P Venook
Adjuvant treatment of colon cancer: what is next?
Current opinion in oncology 2011;23(4):403-9.
2011: Robin K Kelley; Alan P Venook
Prognostic and predictive markers in stage II colon cancer: is there a role for gene expression profiling?
Clinical colorectal cancer 2011;10(2):73-80.
2011: John D Gordan; Wen-Yee Chay; R Kate Kelley; Andrew H Ko; Su-Pin Choo; Alan P Venook
"And what other medications are you taking?".
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(11):e288-91.
2011: Junjie Peng; Weiqi Sheng; Dan Huang; Alan P Venook; Ye Xu; Zuqing Guan; Sanjun Cai
Perineural invasion in pT3N0 rectal cancer: the incidence and its prognostic effect.
Cancer 2011;117(7):1415-21.
2011: Junjie Peng; Wei Chen; Alan P Venook; Weiqi Sheng; Zuqing Guan; Guoxiang Cai; Ye Xu; Sanjun Cai
Long-term outcome of early-stage rectal cancer undergoing standard resection and local excision.
Clinical colorectal cancer 2011;10(1):37-41.
2011: Robin K Kelley; Stephanie L Van Bebber; Kathryn A Phillips; Alan P Venook
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2011;9(1):13-25.
2010: Andrew H Ko; Alan P Venook; Emily K Bergsland; R Kate Kelley; W Michael Korn; Elizabeth Dito; Brian Schillinger; Janet Scott; Jimmy Hwang; Margaret A Tempero
A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.
Cancer chemotherapy and pharmacology 2010;66(6):1051-7.
2010: Robin K Kelley; Alan P Venook
Nonadherence to imatinib during an economic downturn.
The New England journal of medicine 2010;363(6):596-8.
2010: Ki Young Chung; Ira Gore; Lawrence Fong; Alan P Venook; Stephen B Beck; Prudence Dorazio; Peggy J Criscitiello; Diane I Healey; Bo Huang; Jesus Gomez-Navarro; Leonard B Saltz
Phase II study of the anti-cytotoxic T-lymphocyte-associated antigen 4 monoclonal antibody, tremelimumab, in patients with refractory metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(21):3485-90.
2010: Roderich E Schwarz; Ghassan K Abou-Alfa; Jean-Francois H Geschwind; Sunil Krishnan; Riad Salem; Alan P Venook
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.
HPB : the official journal of the International Hepato Pancreato Biliary Association 2010;12(5):313-20.
2010: Sam C Wang; Justin R Parekh; Marlene B Zuraek; Alan P Venook; Emily K Bergsland; Robert S Warren; Eric K Nakakura
Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
Archives of surgery (Chicago, Ill. : 1960) 2010;145(3):276-80.
2010: Riccardo Lencioni; Xiao-Ping Chen; Lucy Dagher; Alan P Venook
Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?
The oncologist 2010;15 Suppl 4():42-52.
2010: Alan P Venook; Christos Papandreou; Junji Furuse; Laura Ladrón de Guevara
The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective.
The oncologist 2010;15 Suppl 4():5-13.
2010: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Jordan D Berlin; J Michael Berry; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Eric Rohren; David P Ryan; Leonard B Saltz; David Shibata; John M Skibber; William Small; Constantinos T Sofocleous; James P Thomas; Alan P Venook; Christopher Willett
NCCN clinical practice guidelines in oncology. Anal carcinoma.
Journal of the National Comprehensive Cancer Network : JNCCN 2010;8(1):106-20.
2009: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard B Saltz; David Shibata; John M Skibber; Constantinos T Sofocleous; James P Thomas; Alan P Venook; Christopher Willett
NCCN Clinical Practice Guidelines in Oncology: rectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(8):838-81.
2009: Paul F Engstrom; Juan Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Anne Covey; Raza A Dilawari; Dayna S Early; Peter C Enzinger; Marwan G Fakih; James Fleshman; Charles Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Edward Lin; Mary F Mulcahy; Sujata Rao; David P Ryan; Leonard B Saltz; David Shibata; John M Skibber; Constantinos T Sofocleous; James P Thomas; Alan P Venook; Christopher Willett
NCCN Clinical Practice Guidelines in Oncology: colon cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(8):778-831.
2009: Robin Kelley; Alan P Venook
Drug development in advanced colorectal cancer: challenges and opportunities.
Current oncology reports 2009;11(3):175-85.
2009: Al B Benson; Thomas A Abrams; Edgar Ben-Josef; P Mark Bloomston; Jean F Botha; Bryan M Clary; Anne Covey; Steven A Curley; Michael D'Angelica; Rene Davila; William D Ensminger; John F Gibbs; Daniel Laheru; Mokenge P Malafa; Jorge A Marrero; Steven G Meranze; Sean J Mulvihill; James Park; James A Posey; Jasgit Sachdev; Riad Salem; Elin R Sigurdson; Constantinos T Sofocleous; Jean-Nicolas Vauthey; Alan P Venook; Laura Williams Goff; Yun Yen; Andrew X Zhu
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2009;7(4):350-91.
2009: Usman Shah; Bert O Neil; Jill Allen; Richard M Goldberg; Stephen A Bernard; Dominic Moore; Alan P Venook; Michael M Morse
A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher.
Gastrointestinal cancer research : GCR 2009;3(2):45-8.
2009: Shenghua Kelly Fan; Alan P Venook; Ying Lu
Design issues in dose-finding Phase I trials for combinations of two agents.
Journal of biopharmaceutical statistics 2009;19(3):509-23.
2009: Richard K Sterling; Lennox Jeffers; Fredric Gordon; Alan P Venook; K Rajender Reddy; Shinji Satomura; Futoshi Kanke; Myron E Schwartz; Morris Sherman
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(1):104-13.
2008: Derrick Wong; Andrew H Ko; Jimmy Hwang; Alan P Venook; Emily K Bergsland; Margaret A Tempero
Serum CA19-9 decline compared to radiographic response as a surrogate for clinical outcomes in patients with metastatic pancreatic cancer receiving chemotherapy.
Pancreas 2008;37(3):269-74.
2008: Andrew H Ko; Elizabeth Dito; Brian Schillinger; Alan P Venook; Zhidong Xu; Emily K Bergsland; Derrick Wong; Janet Scott; Jimmy Hwang; Margaret A Tempero
A phase II study evaluating bevacizumab in combination with fixed-dose rate gemcitabine and low-dose cisplatin for metastatic pancreatic cancer: is an anti-VEGF strategy still applicable?
Investigational new drugs 2008;26(5):463-71.
2008: Robert A Figlin; Elizabeth Brown; Andrew J Armstrong; Wallace Akerley; Al B Benson; Harold J Burstein; David S Ettinger; Phillip G Febbo; Matthew G Fury; Gary R Hudes; Merrill S Kies; Eunice L Kwak; Robert J Morgan; Joanne Mortimer; Karen Reckamp; Alan P Venook; Frank Worden; Yun Yen
NCCN Task Force Report: mTOR inhibition in solid tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 5():S1-20; quiz S21-2.
2008: Ghassan K Abou-Alfa; Alan P Venook
The impact of new data in the treatment of advanced hepatocellular carcinoma.
Current oncology reports 2008;10(3):199-205.
2008: Su-Pin Choo; Alan P Venook
Responding to the rising incidence of hepatocellular carcinoma with targeted therapy.
Gastrointestinal cancer research : GCR 2008;2(2):96-7.
2008: Andrew H Ko; Elizabeth Dito; Brian Schillinger; Alan P Venook; Emily K Bergsland; Margaret A Tempero
Excess toxicity associated with docetaxel and irinotecan in patients with metastatic, gemcitabine-refractory pancreatic cancer: results of a phase II study.
Cancer investigation 2008;26(1):47-52.
2008: Mitchell C Posner; Donna Niedzwiecki; Alan P Venook; Donna R Hollis; Hedy L Kindler; Edward W Martin; Richard L Schilsky; Richard M Goldberg; Robert J Mayer
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903.
Annals of surgical oncology 2008;15(1):158-64.
2007: Bert O Neil; Alan P Venook
Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy.
The oncologist 2007;12(12):1425-32.
2007: Howard S Hochster; Eileen O'Reilly; Jaffer A Ajani; Alan P Venook
Section III: Treatment of Advanced Gastrointestinal Cancers.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S8-S12.
2007: Richard M Goldberg; John L Marshall; Jaffer A Ajani; Philip A Philip; Eileen O'Reilly; Alan P Venook
Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S13-6.
2007: Richard M Goldberg; John L Marshall; Lisa A Kachnic; Alan P Venook
Section I: essentials of ensuring excellence in cancer care.
Gastrointestinal cancer research : GCR 2007;1(6 Suppl):S1-3.
2007: Brian Kavanagh; Andrew Ko; Alan P Venook; Kim Margolin; Herbert Zeh; Michael Lotze; Brian Schillinger; Weihong Liu; Ying Lu; Peggie Mitsky; Marta Schilling; Nadege Bercovici; Maureen Loudovaris; Roy Guillermo; Sun Min Lee; James Bender; Bonnie Mills; Lawrence Fong
Vaccination of metastatic colorectal cancer patients with matured dendritic cells loaded with multiple major histocompatibility complex class I peptides.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(7):762-72.
2007: Su-Pin Choo; Alan P Venook
An alternative therapy for patients with hepatic impairment?
Onkologie 2007;30(10):474-5.
2007: Richard K Sterling; Lennox Jeffers; Fredric Gordon; Morris Sherman; Alan P Venook; K Rajender Reddy; Shinji Satomura; Myron E Schwartz
Clinical utility of AFP-L3% measurement in North American patients with HCV-related cirrhosis.
The American journal of gastroenterology 2007;102(10):2196-205.
2007: J Randolph Hecht; Amita Patnaik; Jordan Berlin; Alan P Venook; Imtiaz Malik; Simon Tchekmedyian; Lynn Navale; Rafael G Amado; Neal J Meropol
Panitumumab monotherapy in patients with previously treated metastatic colorectal cancer.
Cancer 2007;110(5):980-8.
2007: Carmen Allegra; Charles D Blanke; Marc Buyse; Richard M Goldberg; Axel Grothey; Neal J Meropol; Leonard B Saltz; Alan P Venook; Greg Yothers; Daniel Sargent
End points in advanced colon cancer clinical trials: a review and proposal.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3572-5.
2007: Eric K Nakakura; Alan P Venook; Emily K Bergsland
Systemic and regional nonsurgical therapy--what is the optimal strategy for metastatic neuroendocrine cancer?
Surgical oncology clinics of North America 2007;16(3):639-51, x.
2007: Andrew H Ko; Jeanne M Quivey; Alan P Venook; Emily K Bergsland; Elizabeth Dito; Brian Schillinger; Margaret A Tempero
A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer.
International journal of radiation oncology, biology, physics 2007;68(3):809-16.
2007: Alan P Venook; Charles D Blanke; Donna Niedzwiecki; Heinz-Josef Lenz; John R Taylor; Donna R Hollis; Susan Sutherland; Richard M Goldberg
Revisiting the Cancer and Leukemia Group B/Southwest Oncology Group 80405 Trial: a phase III trial of chemotherapy and biologic agents for patients with untreated advanced colorectal adenocarcinoma.
Clinical colorectal cancer 2007;6(7):536-8.
2007: Aliya Qayyum; Gerard K Lee; Benjamin M Yeh; Jill N Allen; Alan P Venook; Fergus V Coakley
Frequency of hepatic contour abnormalities and signs of portal hypertension at CT in patients receiving chemotherapy for breast cancer metastatic to the liver.
Clinical imaging 2007;31(1):6-10.
2006: David L Bartlett; Jordan Berlin; Gregory Y Lauwers; Wells A Messersmith; Nicholas J Petrelli; Alan P Venook
Chemotherapy and regional therapy of hepatic colorectal metastases: expert consensus statement.
Annals of surgical oncology 2006;13(10):1284-92.
2006: Al B Benson; Tanios Bekaii-Saab; Edgar Ben-Josef; Leslie H Blumgart; Bryan M Clary; Steven A Curley; Rene Davila; Craig C Earle; William D Ensminger; John F Gibbs; Daniel Laheru; Alan N Langnas; Sean J Mulvihill; Albert A Nemcek; James A Posey; Elin R Sigurdson; Mika Sinanan; Jean-Nicolas Vauthey; Alan P Venook; Lawrence D Wagman; Timothy J Yeatman
Hepatobiliary cancers. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(8):728-50.
2006: Matthew H Kulke; Emily K Bergsland; David P Ryan; Peter C Enzinger; Thomas J Lynch; Andrew X Zhu; Jeffrey A Meyerhardt; John V Heymach; William E Fogler; Carolyn Sidor; Ann Michelini; Kate Kinsella; Alan P Venook; Charlie S Fuchs
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3555-61.
2006: Mark J Ratain; Antonius A Miller; howard mcleod; Alan P Venook; Merrill J Egorin; Richard L Schilsky
The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(11 Pt 2):3612s-6s.
2006: Supriya Rajpal; Alan P Venook
Targeted therapy in colorectal cancer.
Clinical advances in hematology & oncology : H&O 2006;4(2):124-32.
2006: Andrew H Ko; Elizabeth Dito; Brian Schillinger; Alan P Venook; Emily K Bergsland; Margaret A Tempero
Phase II study of fixed dose rate gemcitabine with cisplatin for metastatic adenocarcinoma of the pancreas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):379-85.
2005: Alan P Venook; Charles D Blanke; Donna Niedzwiecki; Heinz-Josef Lenz; John R Taylor; Donna R Hollis; Susan Sutherland; Richard M Goldberg
Cancer and Leukemia Group B/Southwest Oncology Group trial 80405: a phase III trial of chemotherapy and biologics for patients with untreated advanced colorectal adenocarcinoma.
Clinical colorectal cancer 2005;5(4):292-4.
2005: Andrew H Ko; J Hwang; Alan P Venook; J L Abbruzzese; Emily K Bergsland; Margaret A Tempero
Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.
British journal of cancer 2005;93(2):195-9.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Anal canal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):510-5.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Rectal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):492-508.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Colon cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):468-91.
2005: Alan P Venook
Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
Cancer 2005;103(12):2435-46.
2005: Alan P Venook
Critical evaluation of current treatments in metastatic colorectal cancer.
The oncologist 2005;10(4):250-61.
2005: Francis Y Yao; Milan Kinkhabwala; Jeanne M LaBerge; Nathan M Bass; Robert Brown; Robert K Kerlan; Alan P Venook; Nancy L Ascher; Jean C Emond; John P Roberts
The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2005;5(4 Pt 1):795-804.
2005: Kshama R Mehta; Kentaro Nakao; Marlene B Zuraek; Daniel T Ruan; Emily K Bergsland; Alan P Venook; Dan H Moore; Taku Tokuyasu; Ajay N Jain; Robert S Warren; Jonathan P Terdiman; Frederic M Waldman
Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(5):1791-7.
2004: David S Alberts; Franco M Muggia; James Carmichael; Eric P Winer; Mohammad Jahanzeb; Alan P Venook; Keith M Skubitz; Edgardo Rivera; Joseph A Sparano; Nicholas J DiBella; Simon J Stewart; John J Kavanagh; Alberto Gabizon
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials.
Seminars in oncology 2004;31(6 Suppl 13):53-90.
2004: Richard M Goldberg; Alan P Venook; Richard L Schilsky
Cetuximab in the treatment of colorectal cancer.
Clinical advances in hematology & oncology : H&O 2004;2(11):1-10; quiz 11-12.
2004: Jonathan Whisenant; Alan P Venook
Regional therapy of liver metastases.
Current treatment options in oncology 2004;5(5):427-37.
2004: Alan P Venook
Emerging therapies for metastatic colorectal cancer: focus on EGFR and VEGF inhibition.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2 Suppl 2():S74-84.
2004: Alan P Venook
Key research issues in the management of hepatocellular carcinoma.
Cancer chemotherapy and pharmacology 2004;54 Suppl 1():S87-90.
2004: Jonathan Whisenant; Alan P Venook
Defining the role of hepatic arterial infusion chemotherapy in metastatic colorectal cancer.
Oncology (Williston Park, N.Y.) 2004;18(6):762-8; discussion 769-73.
2004: Michelle E Melisko; R Fox; Alan P Venook
Reactivation of hepatitis C virus after chemotherapy for colon cancer.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2004;16(3):204-5.
2004: Jill Allen; Alan P Venook
Hepatocellular carcinoma: epidemic and treatment.
Current oncology reports 2004;6(3):177-83.
2004: Mark W Wilson; Robert K Kerlan; Nicholas Fidelman; Alan P Venook; Jeanne M LaBerge; Joy Koda; Roy L Gordon
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
Radiology 2004;230(1):287-93.
2003: Alan P Venook
Colorectal metastases confined to the liver: a unique opportunity?
Seminars in oncology 2003;30(4 Suppl 15):34-9.
2003: Alan P Venook
Induction therapy in patients with metastatic colorectal cancer.
Seminars in oncology 2003;30(4 Suppl 12):25-9.
2003: Brendan C Visser; Alan P Venook; Marco G Patti
Adjuvant and neoadjuvant therapy for esophageal cancer: a critical reappraisal.
Surgical oncology 2003;12(1):1-7.
2003: Alan P Venook
Testing the water before diving off the cutting edge.
Annals of surgical oncology 2003;10(4):332-3.
2002: Emily K Bergsland; Alan P Venook
Shedding old paradigms: developing viruses to treat cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(9):2220-2.
2001: Francis Y Yao; Linda D Ferrell; Nathan M Bass; Jessica J Watson; Peter Bacchetti; Alan P Venook; Nancy L Ascher; John P Roberts
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival.
Hepatology (Baltimore, Md.) 2001;33(6):1394-403.
2001: Alan P Venook; Robert S Warren
Therapeutic approaches to metastasis confined to the liver.
Current oncology reports 2001;3(2):109-15.
2000: Alan P Venook
Hepatocellular carcinoma.
Current treatment options in oncology 2000;1(5):407-15.
2000: Al B Benson; Michael A Choti; A M Cohen; James Doroshow; C Fuchs; Krystyna Kiel; Edward W Martin; C McGinn; N J Petrelli; James A Posey; John M Skibber; Alan P Venook; T J Yeatman
NCCN Practice Guidelines for Colorectal Cancer.
Oncology (Williston Park, N.Y.) 2000;14(11A):203-12.
2000: Alan P Venook; Merrill J Egorin; Gary Rosner; Donna Hollis; Sridhar Mani; M Hawkins; John Byrd; R Hohl; D Budman; N J Meropol; Mark J Ratain
Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2780-7.
2000: Emily K Bergsland; Alan P Venook
Hepatocellular carcinoma.
Current opinion in oncology 2000;12(4):357-61.
2000: Alan P Venook; B Althaus; Robert S Warren
Hepatic arterial infusion of chemotherapy for metastatic colorectal cancer.
The New England journal of medicine 2000;342(20):1524; author reply 1526-7.
2000: Alan P Venook
Regional strategies for managing hepatocellular carcinoma.
Oncology (Williston Park, N.Y.) 2000;14(3):347-54; discussion 354, 359, 363-4.
1999: A I Bloom; Roy L Gordon; K H Ahl; R K Kerlan; J M LaBerge; M W Wilson; Alan P Venook; R Warren
Transcatheter embolization for the treatment of misperfusion after hepatic artery chemoinfusion pump implantation.
Annals of surgical oncology 1999;6(4):350-8.
1999: Alan P Venook
Embolization and chemoembolization therapy for neuroendocrine tumors.
Current opinion in oncology 1999;11(1):38-41.
1998: Alan P Venook; Merrill J Egorin; Gary Rosner; T D Brown; Thierry jahan; G Batist; R Hohl; D Budman; M J Ratain; C M Kearns; R L Schilsky
Phase I and pharmacokinetic trial of paclitaxel in patients with hepatic dysfunction: Cancer and Leukemia Group B 9264.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1811-9.
1997: Alan P Venook
Update on hepatic intra-arterial chemotherapy.
Oncology (Williston Park, N.Y.) 1997;11(7):947-57; discussion 961-2, 964, 970.
1997: Alan P Venook
Can a vitamin prevent hepatocellular carcinoma?
Hepatology (Baltimore, Md.) 1997;25(1):249-50.
1996: B V Dorsey; L E Benjamin; F Rauscher; B Klencke; Alan P Venook; Robert S Warren; N Weidner
Intra-abdominal desmoplastic small round-cell tumor: expansion of the pathologic profile.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996;9(6):703-9.
1996: James E Goodnight; Alan P Venook; J Fringer; C Taylor; R Gilden; R A Figlin
Practice guidelines for pancreatic cancer.
The cancer journal from Scientific American 1996;2(3A Suppl):S53-60.
1996: Alan P Venook; James E Goodnight; N G Smith; C Taylor; R Gilden; R A Figlin
Practice guidelines for gastric cancer.
The cancer journal from Scientific American 1996;2(3A Suppl):S45-52.
1996: James E Goodnight; Alan P Venook; M Ames; C Taylor; R Gilden; R A Figlin
Practice guidelines for esophageal cancer.
The cancer journal from Scientific American 1996;2(3A Suppl):S37-43.
1996: Alan P Venook; James E Goodnight; S Kumar; C Taylor; R Gilden; R A Figlin
Practice guidelines for colorectal cancer.
The cancer journal from Scientific American 1996;2(3A Suppl):S23-36.
1996: Alan P Venook; Robert S Warren
Regional chemotherapy approaches for primary and metastatic liver tumors.
Surgical oncology clinics of North America 1996;5(2):411-427.
1995: Alan P Venook; Linda D Ferrell; John P Roberts; J Emond; J W Frye; E Ring; Nancy L Ascher; John R Lake
Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization.
Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 1995;1(4):242-8.
1994: Alan P Venook
Treatment of hepatocellular carcinoma: too many options?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(6):1323-34.
1993: Eric J Small; Alan P Venook; Lloyd Damon
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.
Cancer 1993;72(3):905-8.
1993: Alan P Venook
Liver transplantation for hepatocellular carcinoma.
Hepatology (Baltimore, Md.) 1993;18(1):218-9.
1993: M J Wilkinson; J W Frye; Eric J Small; Alan P Venook; P R Carroll; M L Ernest; R J Stagg
A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma.
Cancer 1993;71(11):3601-4.
1992: J W Park; B Mehrotra; B O Barnett; A D Baron; Alan P Venook
The Sweet syndrome during therapy with granulocyte colony-stimulating factor.
Annals of internal medicine 1992;116(12 Pt 1):996-8.
1992: J W Frye; Alan P Venook; J W Ostroff; Sean J Mulvihill; Robert S Warren; Carlos A Pellegrini; Ernest J Ring; R J Stagg
Hepatic intra-arterial methylene blue injection during endoscopy: a method of detecting gastroduodenal misperfusion in patients receiving hepatic intra-arterial chemotherapy via an implanted pump.
Gastrointestinal endoscopy 1992;38(1):52-4.
1991: R J Stagg; Alan P Venook; J L Chase; B J Lewis; Robert S Warren; M Roh; Sean J Mulvihill; B J Grobman; A A Rayner; D C Hohn
Alternating hepatic intra-arterial floxuridine and fluorouracil: a less toxic regimen for treatment of liver metastases from colorectal cancer.
Journal of the National Cancer Institute 1991;83(6):423-8.
1990: Alan P Venook; R J Stagg; B J Lewis; J L Chase; Ernest J Ring; T P Maroney; D C Hohn
Chemoembolization for hepatocellular carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1108-14.
1988: Alan P Venook; R J Stagg; B J Lewis
Regional chemotherapy for colorectal cancer metastatic to the liver.
Oncology (Williston Park, N.Y.) 1988;2(3):19-26.